Induction of Autophagy and Activation of SIRT-1 Deacetylation Mechanisms Mediate Neuroprotection by the Pomegranate Metabolite Urolithin A in BV2 Microglia and Differentiated 3D Human Neural Progenitor Cells

Mol Nutr Food Res. 2019 May;63(10):e1801237. doi: 10.1002/mnfr.201801237. Epub 2019 Mar 7.

Abstract

Scope: Urolithin A is an anti-inflammatory and neuroprotective gut-derived metabolite from ellagitannins and ellagic acid in pomegranate, berries, and nuts. The roles of SIRT-1 and autophagy in the neuroprotective activity of urolithin A are investigated.

Methods and results: Analyses of culture supernatants from lipopolysaccharide-stimulated BV2 microglia show that urolithin A (2.5-10 µm) produced significant reduction in the production of nitrite, tumor necrosis factor (TNF)-α and IL-6. The anti-inflammatory effect of the compound is reversed in the presence of sirtuin (SIRT)-1 and the autophagy inhibitors EX527 and chloroquine, respectively. Protein analyses reveal reduction in p65 and acetyl-p65 protein. Treatment of BV2 microglia with urolithin A results in increased SIRT-1 activity and nuclear protein, while induction of autophagy by the compound is demonstrated using autophagy fluorescent and autophagy LC3 HiBiT reporter assays. Viability assays reveal that urolithin A produces a neuroprotective effect in APPSwe-transfected ReNcell VM human neural cells, which is reversed in the presence of EX527 and chloroquine. Increase in both SIRT-1 and autophagic activities are also detected in these cells following treatment with urolithin A.

Conclusions: It has been proposed that SIRT-1 activation and induction of autophagy are involved in the neuroprotective activity of urolithin A in brain cells.

Keywords: 3D human neural progenitor cells; SIRT-1; autophagy; microglia; neuroinflammation; neuroprotective; urolithin A.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylation / drug effects
  • Amyloid beta-Peptides / metabolism
  • Animals
  • Autophagy / drug effects*
  • Cell Culture Techniques
  • Cell Differentiation / drug effects
  • Coumarins / pharmacology*
  • Humans
  • Lipopolysaccharides / toxicity
  • Lythraceae / metabolism
  • Mice
  • Microglia / drug effects*
  • Microglia / metabolism
  • Microglia / pathology
  • NF-kappa B / metabolism
  • Neural Stem Cells / drug effects*
  • Neural Stem Cells / metabolism
  • Neuroprotective Agents / pharmacology*
  • Sirtuin 1 / metabolism

Substances

  • Amyloid beta-Peptides
  • Coumarins
  • Lipopolysaccharides
  • NF-kappa B
  • Neuroprotective Agents
  • 3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one
  • SIRT1 protein, human
  • Sirt1 protein, mouse
  • Sirtuin 1